Agios Pharmaceuticals | 营业费用



Operating Expenses 更改 日
AbbVie USD 9.61B 6.98B 2025-03
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Amgen USD 6.86B 85M 2025-03
Arrowhead Research USD 161.51M 2.4M 2025-03
Astellas Pharma JPY 413.25B 17.48B 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Bayer EUR 11.41B 3.22B 2025-03
Biogen USD 1.79B 326.1M 2025-06
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Daiichi Sankyo JPY 377.89B 57.19B 2025-06
Eli Lilly USD 7.32B 1.06B 2025-03
Exelixis USD 354.68M 13.9M 2025-07
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.96B 663M 2025-06
Incyte USD 904.7M 56.97M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Merck USD 9.44B 217M 2025-06
Moderna USD 1.16B 1.06B 2025-03
Novartis USD 9.97B 1.02B 2025-06
Novartis USD 10.15B 579M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12


Agios Pharmaceuticals 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.